Medicamen Biotech fundamental analysis
MEDICAMEQ
375.05
24.20 (6.90%)Last updated on 2 Feb, 2026 | 15:25 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Medicamen Biotech Fundamentals
P/E Ratio
43.4
P/B Ratio
1.73
Div. Yield
0.29
Sector P/E
65.25
Sector P/B
1.2
Sec. Div. Yield
0.58
Medicamen Biotech Fundamentals is currently trading with a P/E Ratio of 43.4, compared to the sector average of 65.25. Its P/B Ratio stands at 1.73, while the sector’s is 1.2. In terms of returns, the stock offers a Dividend Yield of 0.29%, which is than the sector’s 0.58%.
Medicamen Biotech Score Card
Price
Expensive
Growth
Poor
Quality
Poor
Management
Average
On its scorecard, Medicamen Biotech reflects: Price – Expensive, Growth – Poor, Quality – Poor, and Management – Average. Together, these indicators provide a structured view of the company’s fundamentals.
